AAAAAA
Results:
1-8
|
Results: 8
Authors:
WEERASURIYA K
Citation: K. Weerasuriya, DID I TEACH HIM SURVIVAL SKILLS AND HEALTH-CARE PRIORITIES, BMJ. British medical journal, 317(7156), 1998, pp. 461-461
Authors:
WEERASURIYA K
Citation: K. Weerasuriya, MIBEFRADIL - THE SOLE EXCEPTION (VOL 352, PG 823, 1998), Lancet, 352(9142), 1998, pp. 1788-1788
Authors:
WEERASURIYA K
Citation: K. Weerasuriya, MIBEFRADIL - THE SOLE EXCEPTION, Lancet, 352(9130), 1998, pp. 823-824
Authors:
EDDLESTON M
WEERASURIYA K
OLLIARO P
Citation: M. Eddleston et al., ETHICS REVIEW AND CLINICAL-TRIALS - REPLY, Lancet, 351(9108), 1998, pp. 1066-1066
Authors:
BERMAN JD
BADARO R
THAKUR CP
WASUNNA KM
BEHBEHANI K
DAVIDSON R
KUZOE F
PANG L
WEERASURIYA K
BRYCESON ADM
Citation: Jd. Berman et al., EFFICACY AND SAFETY OF LIPOSOMAL AMPHOTERICIN-B (AMBISOME) FOR VISCERAL LEISHMANIASIS IN ENDEMIC DEVELOPING-COUNTRIES, Bulletin of the World Health Organization, 76(1), 1998, pp. 25-32
Authors:
PAPHASSARANG C
TOMSON G
CHOPRAPAWON C
WEERASURIYA K
Citation: C. Paphassarang et al., THE LAO NATIONAL DRUG POLICY - LESSONS ALONG THE JOURNEY, Lancet, 345(8947), 1995, pp. 433-435
Authors:
WEERASURIYA K
JAYAKODY RL
SMITH CAD
WOLF CR
TUCKER GT
LENNARD MS
Citation: K. Weerasuriya et al., DEBRISOQUINE AND MEPHENYTOIN OXIDATION IN SINHALESE - A POPULATION STUDY, British journal of clinical pharmacology, 38(5), 1994, pp. 466-470
Authors:
WEERASURIYA K
Citation: K. Weerasuriya, ESSENTIAL DRUGS AND REGISTRATION OF PHARMACEUTICALS - THE SRI-LANKAN EXPERIENCE, Bulletin of the World Health Organization, 71(2), 1993, pp. 229-235
Risultati:
1-8
|